Meiogenix Names Dr. Gaganpreet Sidhu as Chief Technology Officer
November 14, 2024
Meiogenix a pioneering AgTech company dedicated to advancing agricultural innovation through chromosome editing and targeted recombination, is proud to announce Dr. Gaganpreet Sidhu as its new Chief Technology Officer. Dr. Sidhu, a key member of the Meiogenix team, has been instrumental in leading breakthrough research in DNA repair and recombination, driving the company’s mission to unlock natural genetic diversity in crops.
read more
Meiogenix Hires Ricardo Garcia de Alba as CEO to Lead the Company through its Next Phase of Growth and Evolution to Serve a Broad Market and Customer Base
June 17, 2024
Meiogenix, Inc. an agriculture biotech company that develops disruptive new products based on its proprietary chromosome editing technology, has named Ricardo Garcia de Alba as the company’s new chief executive officer. As CEO, Garcia de Alba will lead Meiogenix toward its mission of helping farmers address challenges involved in the development of advanced varieties, bringing them solutions that unlock the natural genetic diversity of crops.
read more
Dr Neal Gutterson joins Meiogenix board
July 15, 2022
Meiogenix is pleased to announce that Dr. Neal Gutterson has joined the Meiogenix Board of Directors. Meiogenix’ board chair Johan Cardoen welcomes Dr. Gutterson, noting “Neal has been a very impactful leader in the ag industry, with a strong expertise in biotechnology and genomics. He has been a champion of genome editing and other advanced molecular breeding tools to create new value for farmers and consumers. We look forward to his strategic insights for the Meiogenix board”.
read more
Meiogenix joins Cornell’s McGovern Center business incubator
March 17, 2022
Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, has joined Cornell’s McGovern Center business. The Meiogenix U.S. operation will have access to Cornell academic and research resources to focus on advancing tomatoes and other field crops.
read more
Meiogenix Announces $13 Million series A financing round led by Sofinnova Partners
December 14, 2021
Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced today the closing of a $13 million (€11 million) Series A financing round, led by Sofinnova Partners, with participation from Genoa Ventures, Bpifrance, Casdin Capital and Alexandria Venture Investments.
read more
Partnership seeks to unleash DNA’s potential
February 19, 2020
A Cornell professor is collaborating with European partners to engineer maize – the largest staple crop in the world – with desirable traits, from resistance to disease to climate resilience. Wojtek Pawlowski, associate professor of plant genetics, has been studying the mechanisms of genetic recombination for 15 years.
read more
Bayer, Meiogenix collaborate to accelerate agricultural innovation through the development of unique technologies
February 10, 2020
Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications.
read more